When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Erenumab is not associated with significant reductions in weekly attacks in patients with chronic cluster headache vs placebo ...

Long-term follow-up data show that the preventive effects of short-term treatment with abatacept disappear after 4-5 years.

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

Circulate Health, a Seattle health longevity startup, today announced $12 million in seed funding to expand its plasma ...

A pregnant, primiparous 32-year-old woman at 28 weeks’ gestation presented for a routine prenatal visit. Blood work showed thrombocytopenia with platelet count of 60 (reference range 130–380) × 109/L.

More than 37 million people in the United States suffer from migraines. If you’re one of them, you know they can be triggered ...

The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...

More than 37 million people here in the United States suffer from migraines. If you’re one of them, you know they can be caused by different factors like the weather. But how exactly does the ...

The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...

Multiple sclerosis sufferer Braylee Burnett, who turns 18 on Wednesday, learned she can once again resume infusions for her ongoing battle after her insurance company previously had balked at more ...